Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

TMS > DD genomics > Flashcards

DD genomics Flashcards

1
Q

DD are individually rare but collectively common
A. True
B. False

A

A. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why is molecular/genetic diagnosis is important DD?*

A
  1. management - informs management (sometimes)
  2. treatment - helps to access special needs services
  3. prognosis - informs prognosis (sometimes)
  4. reproductive counselling - informs future reproductive decisions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why majority of DD remain undiagnosed after the standard NHS testing?

A
  1. diverse clinical features
  2. diverse molecular causes and inheritance
  3. majority is genetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the range of phenotype associated with DD?*

A
  1. intellucrtual disability (87%)
  2. seizures (24%)
  3. autism spectrum disorder (10%)
  4. congenital heart defects (11%)
  5. hearing impairment (7%)
  6. oral cleft (6%)
  7. scoliosis (5%)
  8. polydactyl (1%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the range of genes and genetic variants that can cause DD*

A
  • > 1500 genes linked to DD
  • genetic variants includes
    1. single nucleotide variant (SNV)
    2. insertion/deletion (indels)
    3. copy number variations (CNVs)
    4. chromosomal aneuploidies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are three main types of DNA variants based on location?

A
  1. intronic/intergenic (non-coding)
    - between genes or axons
    - do not affect protein directly
    - could affect regulation of transcription or splicing
  2. gene/coding/exonic variants
    - silent variant (synonymous)
    - missense variant (non-synomous) changes AA
    - nonsense variant resulting in premature STOP
    - frameshift variants altering reading frame (deletions and insertions)
  3. multi-expo/multigene
    - structural variant can affect multiple genes e.g. copy number
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is two standard diagnostic testing for DD?*

A
  1. molecular genetics - sequencing of genes for genotyping specific small mutations
    - uses sequencing and PCR
    - detects SNVs and indels
    - requires a priori hypothesis
  2. cytogenetics - evaluating the genome for large structural changes that could reflect/explain the phenotype
    - uses karyotyping, FISH, microarrays
    - detects CNVs, chromosomal anueploidies, translocations, inversions
    - do not require a priori hypothesis of cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

name two DD

A
  1. 16p11.2 mcirodeletion/duplication (de novo dominant mutation)
  2. Barnet-biedl syndrome (BBS) (autosomal recessive inheritance)
  3. Prader willi syndrome
  4. down syndrome
  5. SZ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the features of 16p11.2 micro deletion/duplication?

A
  1. CNVs (deletion/duplication-indels)
  2. de novo dominant mutations
  3. 7-8MB of DNA, >60 genes
  4. ID, autism, developmental delay
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does duplication and deletion in 16p11.2 micro deletion/duplication result in?

A

duplication -> risk of being underweight

deletion - risk of obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the features of BBS?

A
  1. SNVs and indels in one of ~20 genes

2. autosomal recessive inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the modern diagnostic testing in DD?

A
  1. standard diagnostic testing
  2. targeted next generation sequencing
  3. genome wide sequencing using NGS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is trio sequencing approach? and why is it powerful?*

A

genetic data from child and both parents are collected which hugely reduces number of candidate casual variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is exome sequencing used to diagnose rare diseases?*

A
  • rare mutations in ~4000 genes are known to cause disease and there are many genes with unknown function
  • therefore, exome sequencing enables the discovery of novel disease causing variation in previously unclassified genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the challenges in working with GWS data?*

A
  1. enormous amount of genetic variation
  2. every genome contains a novel variation
  3. most genetic variation is benign
  4. phenotypic and genotypic heterogeneity
  5. disease inheritance and mechanism is unknown
  6. phenotypes may have more than one genetic cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is DDD?

A

deciphering developmental disorder is UK-collaborative studies of families, NHS and Sanger institute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is Coffin-Siris (ARID1B) syndrome

a. caused by
b. prevalence
c. phenotypic spectrum
d. treatments

A
  1. cause by de novo loss of function of ARID1B - chromatin remodeller; changes DNA accessibility for gene expression
  2. top gene in DDD - diagnosis in 0.7% cases
  3. broad phenotypic spectrum - developmental delay, speech delay, abnormalities of fifth (pinky) fingers or toes, short sighted, feeding difficulties; overlapping with other disorders
  4. no current treatments - can counsel parents about low recurrence risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is Coffin-Siris (ARID1B) syndrome

  1. caused by
  2. its prevalence and rate of diagnosis
  3. phenotypic spectrum
  4. treatments
A
  1. cause by de novo loss of function of ARID1B - chromatin remodeller
  2. top gene in DDD - diagnosis in 0.7% cases
  3. broad phenotypic spectrum - developmental delay, speech delay, abnormalities of fifth (pinky) fingers or toes, short sighted, feeding difficulties; overlapping with other disorders
  4. no current treatments - can counsel parents low recurrence risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how to find out more DD genes?

A
  1. recruit more patients
  2. persuade other researchers to give us their data (i.e. collaborate with other similar cohorts)
  3. share our data with other researchers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the cause and diagnosis for KMT2B mutations?

A
  1. de novo mutations cause dystonia and ID
  2. diagnosis involve es DNA packing and gene expression
  3. patients successfully treated with deep brain stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the advantage of NGS and how is it beneficial for us?*

A
  1. has enabled simultaneous sequencing of all genes
  2. many new disease caused by genes are discovered
  3. large burden of casual de novo mutations through trio sequencing
  4. helps target treatments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the ethical issues in sequencing and what is it caused by?

A
  • caused by data size and broad applicability
  • since variation interpretation is challenging so need to share data
  • concerns for handling incidental and secondary findings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q 
How many variants are in an average genome?
A. 3-4 billion
B.4-5 million
C.500,000
D.20,000
A

B. 4-5 million

24
Q

Which of the following variants change the number of basepairs in the genome?

  1. SNVs
  2. Indels
  3. CNVs
  4. Translocations
  5. Inversions
  6. Aneuploidies
A

indels, CNVs, aneuplodies

25
Q

Why are rare variants rare?

  1. They are new OR very damaging
  2. They are new AND very damaging
  3. They are old OR not very damaging
  4. They are old AND not very damaging
A

they are new OR very damaging

26
Q

what are the endogenous and exogenous sources of variation?

A 
A. endogenous - 
1. hydrolysis 
2. deamination of methylated cytosines 
3. recombination error 
4. segregation error 
5. base pair mismatch during replication 
6. replication slippage
B. exogenous 
1. chemical agents 
2. UV radiation
27
Q

what is the impact of increasing paternal and maternal age on developmental syndromes?

A
  1. there is increased risk of sequence mutations with increase in paternal (mainly) and maternal age, mostly due to replication errors in mitosis in developmental syndromes (e.g. dominant single gene disorders)
  2. structural mutations increase with increase in maternal age due to NDJ or recombination errors in meiosis I and is seen in trisomies (downs syndrome)
28
Q

what is genotyping and what are its types?*

A

genotyping is determining which genetic variants are present in an individual genome

  1. arrays: only assays specific type of variants
    a. SNP-chip - type of DNA microarray that detect polymorphisms in a given population
    b. array-CGH (comparative genomic hybridisation) - determines CNVs of specific regions on microarray
  2. sequencers: only assays variants within specific sequenced region of DNA
29
Q

what is sequencing and what are its types?*

A

it is determining the order of basepairs in a region of DNA

  1. Sanger sequencing - targets specific exons or a single gene
  2. NGS - targets multiple genes or whole genome
30
Q

why is NGS effective for diagnosing paediatric rare diseases?*

A
  1. lots of different genes cause overlapping of phenotype
  2. reduced reproductive fitness therefore, expect ultra-rare variants
    - high burden of de novo mutations (which are easy to find)
    - recessive disease enriched in consanguineous (blood related) populations
    - casual variants (variants and types) will not be present in adults
  3. phenotype arises early, less likely to be influenced by environmental factors
31
Q

what type mutations are significant in in SZ/DD?

A

high burden of de novo mutations

32
Q

ASD is a monogenic disease?
A. True
B. False

A

True, it is monogenic and syndromic forms

33
Q

what are features of ASD?

A
  1. monogenic and syndromic forms
  2. complex multifactorial causes
  3. high burden of de novo mutations and large CNVs
34
Q

what are the factors influencing the onset of ASD?

A
  1. familial background
  2. high risk events - non-genetic factors like paternal age, de Nono mutations and recessive mutations
  3. varying clinical manifestations - comorbidities and overlaping of diseases
35
Q

what is the prevalence and heritability rate of ASD?

A

prevalence ~1.5%

heritability ~50-59%

36
Q

what is the most common phenotype in DD?

A

intelluctual disability

37
Q

what value is considered as intellectual disability?

A

IQ<70

38
Q

why is family trio exam sequencing useful for diagnosing DD’s?

A
  1. determining if recessive variants in child are inherited from carrier parents
  2. finding de novo variants
  3. finding new disease genes
  4. exclusion of benign inherited variants
39
Q

what is the common cause of 1. dominant DD and 2. recessive DD?

A
  1. dominant DD - de novo heterozygous variants

2. recessive DD - inherited variants

40
Q

how do de novo SNVs usually cause disease?

A

through loss of function in dominant disease genes

41
Q

what is haploinsufficiency?

A

only having a single copy of the gene (halpoid) is not enough for normal function so the loss of function mutations cause a dominant phenotype

42
Q

what information can be used to determine if a variant is pathogenic or not?*

A
  1. comparing other patients with the same variant in the same gene
  2. use statistical methods to show enrichment of variants in disease cohort
  3. evaluating whether variant is present in normal controls
  4. evaluating in vitro and in vivo functional data to show the effect of variant
  5. testing segregation in family members and other affected families
43
Q

what is the risk of recurrence of in the following conditions for disease in future pregnancies?

  1. de novo dominant
  2. inherited autosomal dominant
  3. autosomal recessive
  4. X-linked recessive
A
  1. de novo dominant - <1%
  2. inherited autosomal dominant - 50%
  3. autosomal recessive - 25%
  4. X-linked recessive - 50%
44
Q

what is NGLY1 and what does it deficiency result in?

A
  • it is an autosomal recessive gene called N-glycanase 1
  • its deficiency results in impaired ability to deglycosylate proteins, cells accumulate misfiled glycoproteins
  • its results in physical nd neurological symptoms like lack of tears, developmental delay, movement disorder and elevated liver enzymes
45
Q

what are the important issues that should be discussed with the family when taking consent for trio sequencing?*

A
  • consent should be voluntary and informed
  • the issues for discussing during consent are
    1. capacity for consent/assent
    2. likelihood of finding (and not finding a diagnosis)
    3. timescale for finding a diagnosis
    4. potential for treatment
    5. implications for other families
    6. importance of sharing data
    7. potential for incidental findings
46
Q

why only specific genes are highlighted in a condition and how are other variants filtered/excluded?

A
  • variants are excluded if
    1. low quality
    2. common
    3. silent/non-coding
    4. not in known DD disease causing gene
    5. do not fit with family history
47
Q

what does the candidate variant usually include?

A
  1. de novo mutations (in dominant genes)

2. homozygous variants (in recessive genes)

48
Q

why one mutation is determined to be in the diagnosis and not another one?

A
  1. a better fit between the phenotype and the associated gene of the patient (KMT2B)
    - a better fir between the mechanism of disease and type of mutation (KMT2B) in the gene
    - similarity between the patients phenotype and other patient with that mutation
    - definitely pathogenic
49
Q

why is ARID1B not considered for the diagnosis of Billy’s case?

A
  • Missense mutations in ARID1B usually don’t cause disease, only LOF mutations
  • Unstructured protein that is tolerant to missense changes
  • No reports of dystonia in literature, no fiFh finger abnormality in Billy
    May explain part of phenotype??
  • Likely benign variant that does not contribute to the phenotype
50
Q

what is decipher?

A
  1. DECIPHER is a web-based platform which helps clinical and research teams to assess pathogenicity and to share patient data
  2. Integrates genetic and phenotypic data from population and patients
  3. Thousands of variants, mostly in patients with DD
51
Q

SNVs within genes can result in:

  1. Altered amino acid
  2. Deletion of an exon
  3. Truncated protein
  4. No effect (silent)
  5. Frameshi@ mutation
  6. Duplication of an exon
  7. Trinucleotide repeat expansion
A
  1. altered AA
  2. truncated protein
  3. no effect (silent)
52
Q

what is non-disjunction?

A

Failure of homologous chromosomes or sister chromatids to separate equally into daughter cells during mitosis/meiosis

53
Q

what are the features of third generation DNA sequencing?

A
  1. long single module reads (>10,000 bp)
    - can sequence large repeated regions and detect trinucleotide expansion
  2. can detect epigenetic markers (DNA methylation)
  3. higher per base error rate than NGS
    - not yet accurate/cheap enough for WES/WGS
54
Q

what is exome sequencing?

A

sequencing all the axons of all the genes in a genome

55
Q

which NGS does exome sequencing use and bases can it read per person?

A
  1. uses second generation NGS

2. 10 million reads of ~75-150 bases per person

56
Q

Why is NGS so powerful for diagnosing rare disease?*

A
  1. Most rare diseases have a genetic component
  2. Rare diseases are caused by many different genes
  3. Rare diseases are caused by many different types of mutations
  4. NGS offers a gene-agnostic approach to testing
57
Q

what are the features of NGS?

A
  1. massive parallel sequencing of short fragments (“read”) of DNA
  2. fast, cheap, high throughput but computationally intensive
  3. can sequence whole genome and detect most (but not all) variants

TMS (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions